These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 364249)

  • 1. Nonsuppressible insulin-like activity (NSILA) from human serum: recent accomplishments and their physiologic implications.
    Zapf J; Rinderknecht E; Humbel RE; Froesch ER
    Metabolism; 1978 Dec; 27(12):1803-28. PubMed ID: 364249
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein.
    Zapf J; Schoenle E; Jagars G; Sand I; Grunwald J; Froesch ER
    J Clin Invest; 1979 May; 63(5):1077-84. PubMed ID: 447829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-suppressible insulin-like serum activity (NSILA). Physiological importance and survey of the current state of research].
    Zapf J
    Fortschr Med; 1980 Jan; 98(2):66-8. PubMed ID: 7364359
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recent data on somatomedins (insulin-like growth factors) (author's transl)].
    Binoux M
    Ann Endocrinol (Paris); 1980; 41(3):157-92. PubMed ID: 6998350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo.
    Kaufmann U; Zapf J; Torretti B; Froesch ER
    J Clin Endocrinol Metab; 1977 Jan; 44(1):160-6. PubMed ID: 833254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarities between the insulin-like stimulatory effect of human IgG and NSILP.
    Khokher MA; Taylor AM; Dandona P
    Diabetes Res; 1986 Sep; 3(7):373-6. PubMed ID: 3096625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the existence in human serum of large molecular weight nonsuppressible insulin-like activity (NSILA) different from the small molecular weight forms.
    Zapf J; Jagars G; Sand I; Froesch ER
    FEBS Lett; 1978 Jun; 90(1):135-40. PubMed ID: 658429
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum.
    Zapf J; Schoenle E; Froesch ER
    Eur J Biochem; 1978 Jun; 87(2):285-96. PubMed ID: 668694
    [No Abstract]   [Full Text] [Related]  

  • 9. NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart.
    Meuli C; Zapf J; Froesch ER
    Diabetologia; 1978 Apr; 14(4):255-9. PubMed ID: 640301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain.
    Rinderknecht E; Humbel RE
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4379-81. PubMed ID: 1069990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical characterization, and some biological properties of forms I and II.
    Rinderknecht E; Humbel RE
    Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2365-9. PubMed ID: 1065887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsuppressible insulin-like activity and thyroid hormones: major pituitary-dependent sulfation factors for chick embryo cartilage.
    Froesch ER; Zapf J; Audhya TK; Ben-Porath E; Segen BJ; Gibson KD
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2904-8. PubMed ID: 1066701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-suppressible insulin-like activity in Laron's syndrome.
    Kastrup KW; Zapf J
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):414-20. PubMed ID: 425784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent investigation of the nature of nonsuppressible, acid ethanol soluble insulin-like activity (NSILA-S).
    Labhart A; Oelz O; Bünzli HF; Humbel RE; Ritschard WJ; Froesch ER
    Isr J Med Sci; 1972 Jun; 8(6):901-2. PubMed ID: 5051836
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of a specific inhibitor of nonsuppressible insulin-like activity in a partially purified human serum fraction.
    Herington AC; Kuffer AD
    Endocrinology; 1981 Nov; 109(5):1634-40. PubMed ID: 7297496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [NSILA, insulin-like growth factors and somatomedins (author's transl)].
    Froesch ER
    Schweiz Rundsch Med Prax; 1979 Mar; 68(13):412-6. PubMed ID: 432207
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonsuppressible insulin-like activity (NSILA). I. Development of a new sensitive competitive protein-binding assay for determination of serum levels.
    Schalch DS; Heinrich UE; Koch JG; Johnson CJ; Schlueter RJ
    J Clin Endocrinol Metab; 1978 Apr; 46(4):664-71. PubMed ID: 755052
    [No Abstract]   [Full Text] [Related]  

  • 18. Differentiation between carrier-bound forms of non-suppressible insulin-like activity (NSILA) in serum.
    Cornell HJ; Bistrin M; Herington AC
    Int J Biochem; 1985; 17(9):1003-8. PubMed ID: 4065403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin and nonsuppressible insulin-like activity (NSILA-S) stimulate the same glucose transport system via two separate receptors in rat heart.
    Meuli C; Froesch ER
    Biochem Biophys Res Commun; 1977 Apr; 75(3):689-95. PubMed ID: 193498
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence for a biologically active, carrier-bound form of non-suppressible insulin-like activity (NSILA) in human serum.
    Cornell HJ; Herington AC
    Int J Biochem; 1983; 15(4):553-8. PubMed ID: 6852354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.